We show for the first time that eltrombopag is capable of stimulating megakaryopoiesis in CD34+ cells isolated from patients with relapsed multiple myeloma and did so to a degree equivalent to that of rhTPO. This evidence concerns the gene CD34 and AL amyloidosis.